Meningococcal Vaccine Market - Global Outlook and Forecast 2023-2027

Report ID: 699725 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Meningococcal Vaccine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Meningococcal Vaccine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Meningococcal Vaccine Overall Market Size
    2.1 Global Meningococcal Vaccine Market Size: 2021 VS 2027
    2.2 Global Meningococcal Vaccine Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Meningococcal Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Meningococcal Vaccine Players in Global Market
    3.2 Top Global Meningococcal Vaccine Companies Ranked by Revenue
    3.3 Global Meningococcal Vaccine Revenue by Companies
    3.4 Global Meningococcal Vaccine Sales by Companies
    3.5 Global Meningococcal Vaccine Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Meningococcal Vaccine Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Meningococcal Vaccine Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Meningococcal Vaccine Players in Global Market
        3.8.1 List of Global Tier 1 Meningococcal Vaccine Companies
        3.8.2 List of Global Tier 2 and Tier 3 Meningococcal Vaccine Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Meningococcal Vaccine Market Size Markets, 2021 & 2027
        4.1.2 Quadrivalent
        4.1.3 Bivalent
        4.1.4 Others
    4.2 By Type - Global Meningococcal Vaccine Revenue & Forecasts
        4.2.1 By Type - Global Meningococcal Vaccine Revenue, 2016-2021
        4.2.2 By Type - Global Meningococcal Vaccine Revenue, 2022-2027
        4.2.3 By Type - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
    4.3 By Type - Global Meningococcal Vaccine Sales & Forecasts
        4.3.1 By Type - Global Meningococcal Vaccine Sales, 2016-2021
        4.3.2 By Type - Global Meningococcal Vaccine Sales, 2022-2027
        4.3.3 By Type - Global Meningococcal Vaccine Sales Market Share, 2016-2027
    4.4 By Type - Global Meningococcal Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Meningococcal Vaccine Market Size, 2021 & 2027
        5.1.2 Pneumonia
        5.1.3 Meningitis
        5.1.4 Bacteremia
        5.1.5 Others (Arthritis, Conjunctivitis, Urethritis)
    5.2 By Application - Global Meningococcal Vaccine Revenue & Forecasts
        5.2.1 By Application - Global Meningococcal Vaccine Revenue, 2016-2021
        5.2.2 By Application - Global Meningococcal Vaccine Revenue, 2022-2027
        5.2.3 By Application - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
    5.3 By Application - Global Meningococcal Vaccine Sales & Forecasts
        5.3.1 By Application - Global Meningococcal Vaccine Sales, 2016-2021
        5.3.2 By Application - Global Meningococcal Vaccine Sales, 2022-2027
        5.3.3 By Application - Global Meningococcal Vaccine Sales Market Share, 2016-2027
    5.4 By Application - Global Meningococcal Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Meningococcal Vaccine Market Size, 2021 & 2027
    6.2 By Region - Global Meningococcal Vaccine Revenue & Forecasts
        6.2.1 By Region - Global Meningococcal Vaccine Revenue, 2016-2021
        6.2.2 By Region - Global Meningococcal Vaccine Revenue, 2022-2027
        6.2.3 By Region - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
    6.3 By Region - Global Meningococcal Vaccine Sales & Forecasts
        6.3.1 By Region - Global Meningococcal Vaccine Sales, 2016-2021
        6.3.2 By Region - Global Meningococcal Vaccine Sales, 2022-2027
        6.3.3 By Region - Global Meningococcal Vaccine Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Meningococcal Vaccine Revenue, 2016-2027
        6.4.2 By Country - North America Meningococcal Vaccine Sales, 2016-2027
        6.4.3 US Meningococcal Vaccine Market Size, 2016-2027
        6.4.4 Canada Meningococcal Vaccine Market Size, 2016-2027
        6.4.5 Mexico Meningococcal Vaccine Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Meningococcal Vaccine Revenue, 2016-2027
        6.5.2 By Country - Europe Meningococcal Vaccine Sales, 2016-2027
        6.5.3 Germany Meningococcal Vaccine Market Size, 2016-2027
        6.5.4 France Meningococcal Vaccine Market Size, 2016-2027
        6.5.5 U.K. Meningococcal Vaccine Market Size, 2016-2027
        6.5.6 Italy Meningococcal Vaccine Market Size, 2016-2027
        6.5.7 Russia Meningococcal Vaccine Market Size, 2016-2027
        6.5.8 Nordic Countries Meningococcal Vaccine Market Size, 2016-2027
        6.5.9 Benelux Meningococcal Vaccine Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Meningococcal Vaccine Revenue, 2016-2027
        6.6.2 By Region - Asia Meningococcal Vaccine Sales, 2016-2027
        6.6.3 China Meningococcal Vaccine Market Size, 2016-2027
        6.6.4 Japan Meningococcal Vaccine Market Size, 2016-2027
        6.6.5 South Korea Meningococcal Vaccine Market Size, 2016-2027
        6.6.6 Southeast Asia Meningococcal Vaccine Market Size, 2016-2027
        6.6.7 India Meningococcal Vaccine Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Meningococcal Vaccine Revenue, 2016-2027
        6.7.2 By Country - South America Meningococcal Vaccine Sales, 2016-2027
        6.7.3 Brazil Meningococcal Vaccine Market Size, 2016-2027
        6.7.4 Argentina Meningococcal Vaccine Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Meningococcal Vaccine Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Meningococcal Vaccine Sales, 2016-2027
        6.8.3 Turkey Meningococcal Vaccine Market Size, 2016-2027
        6.8.4 Israel Meningococcal Vaccine Market Size, 2016-2027
        6.8.5 Saudi Arabia Meningococcal Vaccine Market Size, 2016-2027
        6.8.6 UAE Meningococcal Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Novartis
        7.1.1 Novartis Corporate Summary
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Meningococcal Vaccine Major Product Offerings
        7.1.4 Novartis Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.1.5 Novartis Key News
    7.2 GSK
        7.2.1 GSK Corporate Summary
        7.2.2 GSK Business Overview
        7.2.3 GSK Meningococcal Vaccine Major Product Offerings
        7.2.4 GSK Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.2.5 GSK Key News
    7.3 Merck
        7.3.1 Merck Corporate Summary
        7.3.2 Merck Business Overview
        7.3.3 Merck Meningococcal Vaccine Major Product Offerings
        7.3.4 Merck Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.3.5 Merck Key News
    7.4 CSL
        7.4.1 CSL Corporate Summary
        7.4.2 CSL Business Overview
        7.4.3 CSL Meningococcal Vaccine Major Product Offerings
        7.4.4 CSL Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.4.5 CSL Key News
    7.5 Baxter
        7.5.1 Baxter Corporate Summary
        7.5.2 Baxter Business Overview
        7.5.3 Baxter Meningococcal Vaccine Major Product Offerings
        7.5.4 Baxter Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.5.5 Baxter Key News
    7.6 JN International Medical Corporation
        7.6.1 JN International Medical Corporation Corporate Summary
        7.6.2 JN International Medical Corporation Business Overview
        7.6.3 JN International Medical Corporation Meningococcal Vaccine Major Product Offerings
        7.6.4 JN International Medical Corporation Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.6.5 JN International Medical Corporation Key News
    7.7 Serum Institute of India
        7.7.1 Serum Institute of India Corporate Summary
        7.7.2 Serum Institute of India Business Overview
        7.7.3 Serum Institute of India Meningococcal Vaccine Major Product Offerings
        7.4.4 Serum Institute of India Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.7.5 Serum Institute of India Key News
    7.8 Bio-Med
        7.8.1 Bio-Med Corporate Summary
        7.8.2 Bio-Med Business Overview
        7.8.3 Bio-Med Meningococcal Vaccine Major Product Offerings
        7.8.4 Bio-Med Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.8.5 Bio-Med Key News
    7.9 China National Biotec Group
        7.9.1 China National Biotec Group Corporate Summary
        7.9.2 China National Biotec Group Business Overview
        7.9.3 China National Biotec Group Meningococcal Vaccine Major Product Offerings
        7.9.4 China National Biotec Group Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.9.5 China National Biotec Group Key News
    7.10 Hualan Bio
        7.10.1 Hualan Bio Corporate Summary
        7.10.2 Hualan Bio Business Overview
        7.10.3 Hualan Bio Meningococcal Vaccine Major Product Offerings
        7.10.4 Hualan Bio Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.10.5 Hualan Bio Key News
    7.11 Walvax
        7.11.1 Walvax Corporate Summary
        7.11.2 Walvax Meningococcal Vaccine Business Overview
        7.11.3 Walvax Meningococcal Vaccine Major Product Offerings
        7.11.4 Walvax Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.11.5 Walvax Key News
    7.12 Zhifei
        7.12.1 Zhifei Corporate Summary
        7.12.2 Zhifei Meningococcal Vaccine Business Overview
        7.12.3 Zhifei Meningococcal Vaccine Major Product Offerings
        7.12.4 Zhifei Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
        7.12.5 Zhifei Key News
8 Global Meningococcal Vaccine Production Capacity, Analysis
    8.1 Global Meningococcal Vaccine Production Capacity, 2016-2027
    8.2 Meningococcal Vaccine Production Capacity of Key Manufacturers in Global Market
    8.3 Global Meningococcal Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Meningococcal Vaccine Supply Chain Analysis
    10.1 Meningococcal Vaccine Industry Value Chain
    10.2 Meningococcal Vaccine Upstream Market
    10.3 Meningococcal Vaccine Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Meningococcal Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Meningococcal Vaccine in Global Market
    Table 2. Top Meningococcal Vaccine Players in Global Market, Ranking by Revenue (2019)
    Table 3. Global Meningococcal Vaccine Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. Global Meningococcal Vaccine Revenue Share by Companies, 2016-2021
    Table 5. Global Meningococcal Vaccine Sales by Companies, (K Dose), 2016-2021
    Table 6. Global Meningococcal Vaccine Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Meningococcal Vaccine Price (2016-2021) & (USD/Dose)
    Table 8. Global Manufacturers Meningococcal Vaccine Product Type
    Table 9. List of Global Tier 1 Meningococcal Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Meningococcal Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Meningococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Global Meningococcal Vaccine Revenue (US$, Mn), 2016-2021
    Table 13. By Type - Global Meningococcal Vaccine Revenue (US$, Mn), 2022-2027
    Table 14. By Type - Global Meningococcal Vaccine Sales (K Dose), 2016-2021
    Table 15. By Type - Global Meningococcal Vaccine Sales (K Dose), 2022-2027
    Table 16. By Application – Global Meningococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
    Table 17. By Application - Global Meningococcal Vaccine Revenue (US$, Mn), 2016-2021
    Table 18. By Application - Global Meningococcal Vaccine Revenue (US$, Mn), 2022-2027
    Table 19. By Application - Global Meningococcal Vaccine Sales (K Dose), 2016-2021
    Table 20. By Application - Global Meningococcal Vaccine Sales (K Dose), 2022-2027
    Table 21. By Region – Global Meningococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
    Table 22. By Region - Global Meningococcal Vaccine Revenue (US$, Mn), 2016-2021
    Table 23. By Region - Global Meningococcal Vaccine Revenue (US$, Mn), 2022-2027
    Table 24. By Region - Global Meningococcal Vaccine Sales (K Dose), 2016-2021
    Table 25. By Region - Global Meningococcal Vaccine Sales (K Dose), 2022-2027
    Table 26. By Country - North America Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - North America Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - North America Meningococcal Vaccine Sales, (K Dose), 2016-2021
    Table 29. By Country - North America Meningococcal Vaccine Sales, (K Dose), 2022-2027
    Table 30. By Country - Europe Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
    Table 31. By Country - Europe Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
    Table 32. By Country - Europe Meningococcal Vaccine Sales, (K Dose), 2016-2021
    Table 33. By Country - Europe Meningococcal Vaccine Sales, (K Dose), 2022-2027
    Table 34. By Region - Asia Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
    Table 35. By Region - Asia Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
    Table 36. By Region - Asia Meningococcal Vaccine Sales, (K Dose), 2016-2021
    Table 37. By Region - Asia Meningococcal Vaccine Sales, (K Dose), 2022-2027
    Table 38. By Country - South America Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
    Table 39. By Country - South America Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
    Table 40. By Country - South America Meningococcal Vaccine Sales, (K Dose), 2016-2021
    Table 41. By Country - South America Meningococcal Vaccine Sales, (K Dose), 2022-2027
    Table 42. By Country - Middle East & Africa Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
    Table 43. By Country - Middle East & Africa Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
    Table 44. By Country - Middle East & Africa Meningococcal Vaccine Sales, (K Dose), 2016-2021
    Table 45. By Country - Middle East & Africa Meningococcal Vaccine Sales, (K Dose), 2022-2027
    Table 46. Novartis Corporate Summary
    Table 47. Novartis Meningococcal Vaccine Product Offerings
    Table 48. Novartis Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 49. GSK Corporate Summary
    Table 50. GSK Meningococcal Vaccine Product Offerings
    Table 51. GSK Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 52. Merck Corporate Summary
    Table 53. Merck Meningococcal Vaccine Product Offerings
    Table 54. Merck Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 55. CSL Corporate Summary
    Table 56. CSL Meningococcal Vaccine Product Offerings
    Table 57. CSL Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 58. Baxter Corporate Summary
    Table 59. Baxter Meningococcal Vaccine Product Offerings
    Table 60. Baxter Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 61. JN International Medical Corporation Corporate Summary
    Table 62. JN International Medical Corporation Meningococcal Vaccine Product Offerings
    Table 63. JN International Medical Corporation Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 64. Serum Institute of India Corporate Summary
    Table 65. Serum Institute of India Meningococcal Vaccine Product Offerings
    Table 66. Serum Institute of India Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 67. Bio-Med Corporate Summary
    Table 68. Bio-Med Meningococcal Vaccine Product Offerings
    Table 69. Bio-Med Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 70. China National Biotec Group Corporate Summary
    Table 71. China National Biotec Group Meningococcal Vaccine Product Offerings
    Table 72. China National Biotec Group Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 73. Hualan Bio Corporate Summary
    Table 74. Hualan Bio Meningococcal Vaccine Product Offerings
    Table 75. Hualan Bio Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 76. Walvax Corporate Summary
    Table 77. Walvax Meningococcal Vaccine Product Offerings
    Table 78. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 79. Zhifei Corporate Summary
    Table 80. Zhifei Meningococcal Vaccine Product Offerings
    Table 81. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
    Table 82. Meningococcal Vaccine Production Capacity (K Dose) of Key Manufacturers in Global Market, 2019-2021 (K Dose)
    Table 83. Global Meningococcal Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
    Table 84. Global Meningococcal Vaccine Production by Region, 2016-2021 (K Dose)
    Table 85. Global Meningococcal Vaccine Production by Region, 2022-2027 (K Dose)
    Table 86. Meningococcal Vaccine Market Opportunities & Trends in Global Market
    Table 87. Meningococcal Vaccine Market Drivers in Global Market
    Table 88. Meningococcal Vaccine Market Restraints in Global Market
    Table 89. Meningococcal Vaccine Raw Materials
    Table 90. Meningococcal Vaccine Raw Materials Suppliers in Global Market
    Table 91. Typical Meningococcal Vaccine Downstream
    Table 92. Meningococcal Vaccine Downstream Clients in Global Market
    Table 93. Meningococcal Vaccine Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Meningococcal Vaccine Segment by Type
    Figure 2. Meningococcal Vaccine Segment by Application
    Figure 3. Global Meningococcal Vaccine Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Meningococcal Vaccine Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Meningococcal Vaccine Revenue, 2016-2027 (US$, Mn)
    Figure 7. Meningococcal Vaccine Sales in Global Market: 2016-2027 (K Dose)
    Figure 8. The Top 3 and 5 Players Market Share by Meningococcal Vaccine Revenue in 2020
    Figure 9. By Type - Global Meningococcal Vaccine Sales Market Share, 2016-2027
    Figure 10. By Type - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
    Figure 11. By Type - Global Meningococcal Vaccine Price (USD/Dose), 2016-2027
    Figure 12. By Application - Global Meningococcal Vaccine Sales Market Share, 2016-2027
    Figure 13. By Application - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
    Figure 14. By Application - Global Meningococcal Vaccine Price (USD/Dose), 2016-2027
    Figure 15. By Region - Global Meningococcal Vaccine Sales Market Share, 2016-2027
    Figure 16. By Region - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
    Figure 17. By Country - North America Meningococcal Vaccine Revenue Market Share, 2016-2027
    Figure 18. By Country - North America Meningococcal Vaccine Sales Market Share, 2016-2027
    Figure 19. US Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 20. Canada Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 21. Mexico Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 22. By Country - Europe Meningococcal Vaccine Revenue Market Share, 2016-2027
    Figure 23. By Country - Europe Meningococcal Vaccine Sales Market Share, 2016-2027
    Figure 24. Germany Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 25. France Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 26. U.K. Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 27. Italy Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 28. Russia Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 29. Nordic Countries Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 30. Benelux Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 31. By Region - Asia Meningococcal Vaccine Revenue Market Share, 2016-2027
    Figure 32. By Region - Asia Meningococcal Vaccine Sales Market Share, 2016-2027
    Figure 33. China Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 34. Japan Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 35. South Korea Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 36. Southeast Asia Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 37. India Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 38. By Country - South America Meningococcal Vaccine Revenue Market Share, 2016-2027
    Figure 39. By Country - South America Meningococcal Vaccine Sales Market Share, 2016-2027
    Figure 40. Brazil Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 41. Argentina Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 42. By Country - Middle East & Africa Meningococcal Vaccine Revenue Market Share, 2016-2027
    Figure 43. By Country - Middle East & Africa Meningococcal Vaccine Sales Market Share, 2016-2027
    Figure 44. Turkey Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 45. Israel Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 46. Saudi Arabia Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 47. UAE Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
    Figure 48. Global Meningococcal Vaccine Production Capacity (K Dose), 2016-2027
    Figure 49. The Percentage of Production Meningococcal Vaccine by Region, 2020 VS 2027
    Figure 50. Meningococcal Vaccine Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Meningococcal Vaccine Market In Pharma & Healthcare report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Meningococcal Vaccine Market In Pharma & Healthcare report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Meningococcal Vaccine Market In Pharma & Healthcare report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports